tiprankstipranks
Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market

Cell Source (CLCS) Income Statement

7 Followers

Cell Source Income Statement

Last quarter (Q ), Cell Source's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Cell Source's net income was $-1.65M. See Cell Source’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 3.32M$ 4.18M$ 4.02M$ 3.78M$ 3.81M$ 2.01M
Operating Income
$ -2.98M$ -4.18M$ -4.33M$ -3.78M$ -3.81M$ -2.01M
Net Non Operating Interest Income Expense
-$ -170.87K$ -380.23K$ -664.13K$ -307.95K$ -478.65K
Other Income Expense
$ -41.92K$ 685.19K$ 665.01K$ 117.22K$ -362.35K$ 367.35K
Pretax Income
$ -2.06M$ -5.05M$ -5.37M$ -4.56M$ -4.48M$ -2.12M
Tax Provision
-$ -754.66K$ -1.77M---
Earnings From Equity Interest Net Of Tax
---$ 16.98K--
Net Income Common Stockholders
$ -5.18M$ -6.33M$ -6.45M$ -5.44M$ -5.22M$ -2.57M
Basic EPS
$ -0.13$ -0.18$ -0.19-$ -0.18$ -0.09
Diluted EPS
$ -0.13$ -0.18$ -0.19$ -0.19$ -0.18$ -0.09
Basic Average Shares
$ 112.47M$ 34.84M$ 33.12M$ 29.10M$ 28.33M$ 27.55M
Diluted Average Shares
$ 112.47M$ 34.84M$ 33.12M$ 29.10M$ 28.33M$ 27.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 3.32M$ 4.18M$ 4.02M$ 3.78M$ 3.81M$ 2.01M
Net Income From Continuing And Discontinued Operation
$ -4.27M$ -5.17M$ -5.47M$ -4.56M$ -4.48M$ -2.12M
Normalized Income
$ -1.62M$ -5.81M--$ -4.34M$ -2.68M
Interest Expense
----$ 307.95K$ 478.65K
EBIT
$ -2.06M$ -4.88M$ -4.99M$ -4.16M$ -4.17M$ -1.64M
EBITDA
$ -936.80K$ -4.60M$ -4.26M$ -3.86M$ -4.17M$ -1.64M
Currency in USD

Cell Source Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis